These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21507868)

  • 21. Transplant pharmacy: 30 years of improving patient care.
    Burckart GJ
    Ann Pharmacother; 2007 Jul; 41(7):1261-3. PubMed ID: 17595304
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
    Malone DC; Abarca J; Skrepnek GH; Murphy JE; Armstrong EP; Grizzle AJ; Rehfeld RA; Woosley RL
    Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Change in public satisfaction with community pharmacy services in Tartu, Estonia, between 1993 and 2005.
    Volmer D; Bell JS; Janno R; Raal A; Hamilton DD; Airaksinen MS
    Res Social Adm Pharm; 2009 Dec; 5(4):337-46. PubMed ID: 19962677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
    Blake KB; Madhavan SS
    Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety culture assessment in community pharmacy: development, face validity, and feasibility of the Manchester Patient Safety Assessment Framework.
    Ashcroft DM; Morecroft C; Parker D; Noyce PR
    Qual Saf Health Care; 2005 Dec; 14(6):417-21. PubMed ID: 16326787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of pharmacy quality metrics at the pharmacy level should be our goal.
    Brown LM
    J Am Pharm Assoc (2003); 2009; 49(2):153. PubMed ID: 19289340
    [No Abstract]   [Full Text] [Related]  

  • 27. Private pharmacy practice and regulation. A randomized trial in Lao P.D.R.
    Stenson B; Syhakhang L; Lundborg CS; Eriksson B; Tomson G
    Int J Technol Assess Health Care; 2001; 17(4):579-89. PubMed ID: 11758301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical consultations in community pharmacies: utility of the Roter Interaction Analysis System to study pharmacist-patient communication.
    Cavaco A; Roter D
    Int J Pharm Pract; 2010 Jun; 18(3):141-8. PubMed ID: 20509347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FIP Perspectives: Realising global patient safety goals requires an integrated approach with pharmacy at the core.
    Bader L; Kusynová Z; Duggan C
    Res Social Adm Pharm; 2019 Jul; 15(7):815-817. PubMed ID: 30846369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Believing what we know: pharmacy provides value.
    Breland BD
    Am J Health Syst Pharm; 2007 Jun; 64(12):1284-91. PubMed ID: 17563051
    [No Abstract]   [Full Text] [Related]  

  • 32. Health care at a crossroad: what will the pharmacists' role be?
    Gurney MK
    Res Social Adm Pharm; 2009 Dec; 5(4):302-4. PubMed ID: 19962673
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmaceutical care in community pharmacies: practice and research in Brazil.
    de Castro MS; Correr CJ
    Ann Pharmacother; 2007 Sep; 41(9):1486-93. PubMed ID: 17666581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of a community pharmacy-based rural asthma management service.
    Saini B; Filipovska J; Bosnic-Anticevich S; Taylor S; Krass I; Armour C
    Aust J Rural Health; 2008 Apr; 16(2):100-8. PubMed ID: 18318852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Summary of the executive session on critical threats to the pharmacy supply chain and the effects on patient care.
    Am J Health Syst Pharm; 2013 Oct; 70(19):1689-98. PubMed ID: 24048606
    [No Abstract]   [Full Text] [Related]  

  • 36. Innovations in pharmacy practice: peering into the crystal ball.
    Ried LD
    J Am Pharm Assoc (2003); 2013; 53(2):134-5. PubMed ID: 23571619
    [No Abstract]   [Full Text] [Related]  

  • 37. The regulation of pharmacy ownership in Australia: the potential impact of changes to the health landscape.
    Hattingh HL
    J Law Med; 2011 Sep; 19(1):147-54. PubMed ID: 21988016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutical care in community pharmacy: practice and research in the Netherlands.
    van Mil JW
    Ann Pharmacother; 2005 Oct; 39(10):1720-5. PubMed ID: 16144881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are independent pharmacies in need of special care? An argument against an antitrust exemption for collective negotiations of pharmacists.
    Rosenthal DB
    Yale J Health Policy Law Ethics; 2013; 13(1):198-252. PubMed ID: 23815043
    [No Abstract]   [Full Text] [Related]  

  • 40. Factors related with prescription requirement to dispense in Spain.
    Caamaño Isorna F; Tomé-Otero M; Takkouche B; Figueiras A
    Pharmacoepidemiol Drug Saf; 2004 Jun; 13(6):405-9. PubMed ID: 15170771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.